ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.3452C>G (p.Ala1151Gly)

gnomAD frequency: 0.00001  dbSNP: rs587782625
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000132010 SCV000187069 uncertain significance Hereditary cancer-predisposing syndrome 2021-06-19 criteria provided, single submitter clinical testing The p.A1151G variant (also known as c.3452C>G), located in coding exon 6 of the MSH6 gene, results from a C to G substitution at nucleotide position 3452. The alanine at codon 1151 is replaced by glycine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV000234247 SCV000283807 likely benign Hereditary nonpolyposis colorectal neoplasms 2023-11-15 criteria provided, single submitter clinical testing
Counsyl RCV000412120 SCV000488229 uncertain significance Lynch syndrome 5 2016-01-27 criteria provided, single submitter clinical testing
GeneDx RCV000484116 SCV000567286 uncertain significance not provided 2023-10-10 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with uterine cancer (Bhai et al., 2021); This variant is associated with the following publications: (PMID: 17531815, 21120944, 12019211, 34326862)
Mendelics RCV000708888 SCV000837915 uncertain significance Lynch syndrome 2018-07-02 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000132010 SCV000908420 uncertain significance Hereditary cancer-predisposing syndrome 2022-10-11 criteria provided, single submitter clinical testing This missense variant replaces alanine with glycine at codon 1151 of the MSH6 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 3/251416 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Myriad Genetics, Inc. RCV000412120 SCV004018990 uncertain significance Lynch syndrome 5 2023-03-29 criteria provided, single submitter clinical testing This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000484116 SCV004221224 uncertain significance not provided 2023-07-08 criteria provided, single submitter clinical testing To the best of our knowledge, this variant has not been reported in individuals with MSH6-related conditions in the published literature. In a large case-control study, this variant has been observed in an individual with breast cancer (PMID: 33471991 (2021), see also LOVD (http://databases.lovd.nl/shared/genes/MSH6)). The frequency of this variant in the general population, 0.000026 (3/113722 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.